{"id":"W4410861500","doi":"10.31557/apjcp.2025.26.5.1529","title":"Efficacy and Safety of Lenvatinib versus Atezolizumab Plus Bevacizumab in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Asian Pacific Journal of Cancer Prevention","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Universitas Udayana","keywords":"Atezolizumab; Lenvatinib; Medicine; Bevacizumab; Hepatocellular carcinoma; Oncology; Meta-analysis; Internal medicine; Cancer; Chemotherapy; Nivolumab; Sorafenib; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01531917,0.002900483,0.02287697,0.007862381,0.0006879735,0.00346063,0.00244672,0.002176311,0.003391872],"category_scores_gemma":[0.03241568,0.001525642,0.04463186,0.0078675,0.0007762549,0.002001469,0.001565375,0.001686562,0.0003366786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00298632,"about_ca_system_score_gemma":0.004870574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006117096,"about_ca_topic_score_gemma":0.01368095,"domain_scores_codex":[0.9896253,0.004521366,0.003437608,0.0009099785,0.001254364,0.0002514317],"domain_scores_gemma":[0.9820753,0.01260223,0.003108343,0.0004376816,0.001521988,0.0002545434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001494785,0.00002568756,0.001760258,0.3959001,0.5906649,0.0001025614,0.00007290565,0.0004473814,0.0001812708,0.0001047549,0.0003739682,0.008871383],"study_design_scores_gemma":[0.000346843,0.0001464931,0.001294231,0.02086373,0.97592,0.00006591826,0.00002871512,0.0001487261,0.00007784541,0.0001205935,0.0009691903,0.00001781586],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003431239,0.9946752,0.0005555613,0.0001805624,0.0001276284,0.0003570387,0.0004363856,0.00002393509,0.000212464],"genre_scores_gemma":[0.1345219,0.8586155,0.002593015,0.0009608408,0.0002942041,0.001609905,0.0009633861,0.00004245301,0.0003987555],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02287697,"threshold_uncertainty_score":0.08101648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.116385889156416,"score_gpt":0.3616738043371305,"score_spread":0.2452879151807145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}